Latest Articles
- Hepatitis C update: Implications of the blood transfusion “lookback”
In the coming years, physicians will have to inform up to 300,000 blood recipients that they may have contracted hepatitis C.
- Lipid formulations of amphotericin B
New lipid formulations of amphotericin B are less nephrotoxic and can he given in higher doses than standard formulations, but improved efficacy has not been proved. With an illustration explaining the pharmacokinetics of these preparations.
- Our new understanding of heart failure: The role of beta-blockers in treatment
Beta-blockers can stop the downward spiral of heart failure by improving the biology of the myocyte. With an illustration showing the abnormal remodeling process in heart failure.
- The heart failure pandemic: Changing patterns, costs, and treatment strategies
As the definition of heart failure changes, new treatment strategies are needed to control costs and reduce suffering.
- New Series: Heart Failure Update
Heart failure is going to be every physician’s problem, regardless of specialty.
- New options for diagnosing and treating acromegaly
Insulin-like growth factor 1 (IGF-1) is a more sensitive clinical marker of acromegaly than growth hormone. Two new somatostatin analogs are available for treatment. With an illustration explaining the growth hormone cascade.